Skip to main content
Fig. 5 | Clinical Epigenetics

Fig. 5

From: ATHENA: an independently validated autophagy-related epigenetic prognostic prediction model of head and neck squamous cell carcinoma

Fig. 5

Decision curve analysis and nomogram of ATHENA. The net benefit (NB) and net reduction (NR) of patients avoided unnecessary interventions are given at threshold (0.4) for both 36-month (A, B) and 60-month (C, D) survival. E For the nomogram of ATHENA model, the value of each predictor can be converted into the corresponding points according to the axis in the top of nomogram. The sum of points for each predictor can correspond to the total points axis at the bottom of the nomogram and further be used to estimate the patient's 36- and 60-month survival rate

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us